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Introduction
Tinnitus is characterized by the perception of sound in the 
absence of an external stimulus. It is a common condition in 
both adult and pediatric populations and can result in con-
siderable functional impairment.1-3 In the military veteran 
population, tinnitus is the most prevalent service-connected 
disability, with over 1.1 million veterans collecting disabil-
ity.4 Intolerable and bothersome tinnitus can lead to anxiety, 
depression, and insomnia, which all can negatively impact 
an individual’s quality of life.5-7 As a result, those with tin-
nitus can have a poor quality of life, mental distress, and 
disability.8
Various treatment modalities have been introduced and 
implemented for tinnitus therapy, but the evidence regard-
ing their effectiveness is limited. Recent clinical practice 
guidelines published by the American Academy of 
Otolaryngology–Head and Neck Surgery (AAO-HNS) only 
endorsed cognitive behavioral therapy (CBT) as a 
recommended modality and regarded sound therapy as an 
option.9 Both CBT and sound therapies have been increas-
ingly employed in the recent decade to reduce tinnitus loud-
ness. The Veteran’s Administration (VA) has developed a 
comprehensive protocol on progressive tinnitus manage-
ment (PTM), which has been used in VA hospitals and clin-
ics.10 Sound therapy can serve as a distraction tool from 
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Abstract
Objectives: To determine the effectiveness of a customized sound therapy and compare its effectiveness to that of 
masking with broadband noise.
Methods: Subjects were randomized to receive either customized sound therapy or broadband noise for 2 hours per 
day for 3 months and then switched to the other treatment after a washout period. The outcome variables were tinnitus 
loudness (scored 0-10), Tinnitus Handicap Inventory (THI), Beck Anxiety Inventory (BAI), minimum masking levels (MML), 
and residual inhibition (RI).
Results: Eighteen subjects completed the study. Mean age was 53 ± 11 years, and mean tinnitus duration was 118 ± 99 
months. With customized sound therapy, mean loudness decreased from 6.4 ± 2.0 to 4.9 ± 1.9 (P = .001), mean THI 
decreased from 42.8 ± 21.6 to 31.5 ± 20.3 (P < .001), mean BAI decreased from 10.6 ± 10.9 to 8.3 ± 9.9 (P = .01), and 
MML decreased from 22.3 ± 11.6 dB SL to 17.2 ± 10.6 dB SL (P = .005). After 3 months of broadband noise therapy, only 
BAI and, to a lesser degree, MML decreased (P = .003 and .04, respectively).
Conclusions: Customized sound therapy can decrease the loudness and THI scores of tinnitus patients, and the results 
may be superior to broadband noise.
Keywords
tinnitus, sound therapy, customized sound therapy, clinical trial, masking, tinnitus handicap inventory, minimum masking 
level, residual inhibition
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tinnitus and provide a soothing sensation to the patient by 
masking tinnitus. Most recently, customized sound thera-
pies have been developed to tailor the acoustic energy based 
on patient’s tinnitus pitch and hearing. Our group has devel-
oped the harmonic sound therapy, which is a customized 
masking strategy specifically designed to deliver targeted 
acoustic energy. This sound therapy uses patients’ pitch-
matched frequency along with the intra-aural and inter-fre-
quency attenuation characteristics and creates a sound file 
that is composed of a series of narrow-band noise peaks 
centered on the pitch-matched frequency and its first and 
fourth subharmonics. This technique would allow for 
reduced acoustic energy delivery while leaving a portion of 
the mid-frequencies unmasked.11,12 In this study, we sought 
to investigate the effectiveness of the harmonic sound ther-
apy in a clinical trial and compare its result to that of simple 
masking with broadband noise sound therapy.
Materials and Methods
Subject Enrollment and Pretrial Assessments
Upon approval by the Institutional Review Board at our 
institution, participants were enrolled in the study through 
our clinic and included interested subjects from our affili-
ated VA hospital. The inclusion criteria included age greater 
than or equal to 18 years of age and presence of tinnitus for 
at least 3 months or more. The exclusion criteria included 
patients with abnormalities of the ear canal, active illicit 
drug use or alcohol dependence, active ear infections, his-
tory of psychosis, pulsatile tinnitus, and those currently 
under another sound or masking therapy for tinnitus. Pretrial 
procedures included obtaining informed consent, obtaining 
pretreatment standard audiometry, and ensuring a previous 
consultation with an otolaryngologist to determine that there 
is no treatable cause of the tinnitus (eg, cerumen impaction). 
Data on demographics (age and gender), tinnitus character-
istics, and psychoacoustic assessments were obtained.
The subjects were queried regarding their tinnitus char-
acteristics. Tinnitus duration was recorded in months. 
Subjects were asked about tinnitus characteristics including 
the quality of the tinnitus sound (ringing/tonal, buzzing/
hissing, or multiple sounds) and localization of the sounds. 
In addition, subjects were asked to rate their tinnitus loud-
ness on a scale of 0 to 10 based on the visual analog scale 
(VAS) and complete the questionnaire for Tinnitus Handicap 
Inventory (THI), which were the primary outcomes mea-
sured. Additionally, the subjects were asked to complete 
questionnaires for the Beck Anxiety Index (BAI) and Beck 
Depression Index (BDI), which were used to assess anxiety 
and depressive levels in tinnitus patients as secondary out-
come measures.
Psychoacoustic assessments were performed follow-
ing a standard audiometry. These assessments included 
investigating subjects’ tinnitus pitch, loudness, and noise 
match as well as minimum masking level (MML) and 
residual inhibition (RI). Audiometry was performed using 
a calibrated Grason-Stadler Audiometer (Model GSI 16, 
Eden Prairie, Minnesota, USA) in a double-walled sound-
proof room using EarTone 3A insert earphones 
(Audiometrics, Oceanside, California, USA). Tinnitus 
pitch was matched by first presenting sound stimuli at 1 
kHz and asking the subjects whether their tinnitus had a 
higher or lower pitch. Based on their response, an octave 
frequency higher or lower was presented. This was con-
tinued until the pitch was narrowed down to within an 
octave. Inter-octave frequencies were then presented to 
determine a pitch match to the closest half-octave. The 
sound stimuli were presented to the contralateral ear. If 
the subject had bilateral tinnitus, then it was presented to 
either the better hearing ear or a random ear if the hearing 
status was the same. The tones were presented at 10 dB 
SL. The inter-octaves were also tested to yield the closest 
match. Once the subject chose the closest match, tones an 
octave higher and lower were presented again to account 
for possible octave confusion. Narrow band noise match-
ing served to determine whether the tinnitus sounded 
more like a pure tone or narrow band noise.
Next, MML was tested. First, broadband noise hearing 
thresholds were obtained, and the noise was then pre-
sented binaurally in +1 dB SL steps above the threshold of 
the better hearing ear. This was continued until the subject 
stated that their tinnitus had become inaudible. Residual 
inhibition was measured after MML. The RI test evaluates 
the post-masking effects to determine if the tinnitus can be 
temporarily suppressed.2,13 For testing RI, broadband 
noise was presented for 60 seconds at 10 dB above MML, 
and then the subject was asked whether there was a change 
in their tinnitus loudness. The responses were categorized 
into (1) worse, indicating tinnitus becoming louder after 
60 seconds; (2) no RI, indicating no changes in tinnitus 
loudness; (3) partial RI, indicating a partial reduction in 
tinnitus loudness; and (4) complete RI, indicating not 
hearing their tinnitus. If the subject reported a partial or 
complete RI, the length of time until the tinnitus loudness 
reached its pretest level was recorded and reported as RI 
duration.
Sound Therapy Protocols
Adobe Audition version 3.0 (Adobe Systems Incorporated, 
San Jose, California, USA) was used to create broadband 
noise for the noncustomized sound therapy. Broadband 
noise had a spectral frequency of 1, meaning that equal pro-
portions of all frequencies were present. The customized 
sound therapy was created using the Mind:Set Technologies 
software (available at www.beyondtinnitus.com), which 
has been previously described.11,12 Pitch matching for the 
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customization process was performed within the software 
using pure tones for subjects with tonal/ringing tinnitus, and 
narrowband noise stimuli were used for non-tonal tinnitus. 
Those with multiple tinnitus sounds were asked to match 
their loudest tinnitus sound. The stimuli were presented bin-
aurally. The software took into account the subject’s tinni-
tus pitch-matched frequency along with the intra-aural and 
inter-frequency attenuation characteristics and created a 
sound file that was composed of a series of narrow-band 
noise peaks centered on the pitch-matched frequency and 
its first and fourth subharmonics. The width of these bands 
was one-half octave of the center frequency (Figure 1). The 
result was a file that sounded similar to broadband noise but 
with less acoustic energy. This sound file was then mixed 
with 6 hours of classical music and uploaded onto an MP3 
player (Sansa Clip+ MP3 Player, SanDisk Corporation, 
Milpitas, California, USA) and given to the subjects along 
with open ear headphones AirDrives Interactive Stereo ear-
phones (AirDrives, San Diego, California, USA). All sub-
jects were asked to use the MP3 player to demonstrate 
whether they were capable of playing the sound therapy and 
listening to it for 2 minutes. Noncompliance was defined as 
failing to listen to the sound therapy files for at least 2 hours 
per day every day.
Study Design and Follow-up
The clinical trial was designed as a randomized crossover 
study with 2 arms. The first arm started with 3 months of 
broadband noise therapy (noncustomized), and the second 
arm started with customized sound therapy (Figure 2). 
Subjects were assigned to either arm using block random-
ization with each block containing 4 patients. Subjects were 
instructed to listen to the sound therapy for at least 2 hours 
per day every day for the duration of the study. They were 
also instructed to adjust the intensity of the sound therapies 
as needed to a level that would barely mask their tinnitus. 
After 3 months, tinnitus loudness on VAS, THI, BAI, BDI, 
MML, RI, and RI duration were repeated. After a 1-month 
washout period to reduce the possibility of carryover effect, 
the subjects were switched to the other arm and received the 
other therapy for another 3 months. At 7 months from the 
start of the study, the same measurements were repeated. 
This crossover design allowed each subject to receive both 
therapies and serve as their own control.
Statistical Analysis
Simple descriptive statistics were provided on demograph-
ics and tinnitus characteristics. Mean and range of values 
were calculated for hearing thresholds. Mean, standard 
deviation (SD), and median were calculated for VAS, THI, 
BAI, BDI, MML, and RI. The Wilcoxon signed-rank test 
was used to analyze the changes in these variables. The 
Mann-Whitney U test was used to compare the changes 
between customized and noncustomized sound therapies. A 
P-value of less than .05 was considered as statistical level of 
significance. All analyses were performed using PASW 
Statistics 18.0.0 (SPSS Inc, Chicago, Illinois, USA).
Results
Twenty-three subjects were enrolled in the study. Of these, 
5 subjects were noncompliant with treatment or lost to fol-
low-up. No significant differences between these subjects 
and those who completed the study were noted with respect 
to the measured independent and outcome variables. As 
such, 18 subjects completed the study procedures. The aver-
age age was 53 ± 11 years (range, 26-69 years). Table 1 
summarizes the demographics and tinnitus characteristics 
of study subjects. The mean tinnitus duration was 118 ± 99 
months (range, 15-312 months). The tinnitus pitch match 
averaged at 6958 ± 3754 Hz (range, 250-12 000 Hz).
Tables 2 and 3 present the outcome measurements at 
baseline and at 3 months after customized sound and broad-
band noise therapies. After 3 months of customized sound 
therapy, the mean loudness rating on VAS decreased by 
23% from 6.4 ± 2.0 to 4.9 ± 1.9 (P = .001), and the mean 
THI scores decreased by 26% from 42.8 ± 21.6 to 31.5 ± 
Figure 1. Spectrum analysis of a sample customized sound 
therapy for a patient with tinnitus pitch matched at 6 kHz and 
high-frequency sensorineural hearing loss. More sound is targeted 
around 6 kHz and a narrowband sound at 3 kHz and 375 Hz.
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20.3 (P < .001). The mean BAI scores decreased by 22%, 
from 10.6 ± 10.9 to 8.3 ± 9.9 (P = .01). There was no sig-
nificant statistical change in the mean BDI scores. The 
mean MML also decreased by 23% from 22.3 ± 11.6 to 17.2 
± 10.6 (P = .005). The residual inhibition type and duration 
did not change significantly; however, the number of sub-
jects with complete RI increased from 1 to 4 (6%-22%).
Broadband noise therapy in the other arm of the trial 
only revealed significant improvements in two of the out-
come measurements (Table 3). The mean BAI scores 
decreased by 25% from 10.6 ± 10.9 to 7.9 ± 9.8 (P = .003), 
and the mean MML decreased by 10% from 22.3 ± 11.6 to 
20.0 ± 9.9 (P = .04). No statistically significant changes 
were noted in the mean loudness ratings, THI scores, BDI 
scores, or RI type and duration. There was no statistically 
significant difference in any of the primary or secondary 
outcomes in the groups that received either customized 
sound therapy or broadband noise first compared to those 
who received it after the crossover (P > .05).
Direct comparison of the 2 therapy arms revealed that 
the changes in tinnitus loudness and THI with the custom-
ized sound therapy were statistically greater than those of 
the broadband noise therapy (P = .03 and P = .002, respec-
tively). The changes in BAI, BDI, and MML were not sta-
tistically different between the 2 therapy arms (P = .5, P = 
.4, and P = .5, respectively).
Discussion
The results from the current study revealed that the custom-
ized sound therapy protocol can improve tinnitus loudness 
and handicap. Tinnitus has a considerable impact and bur-
den on the US health care and economy, and the need for a 
cost-effective, widely accessible, and effective treatment 
protocol for tinnitus has long been emphasized. While much 
work has been done on tinnitus epidemiology and manage-
ment options, current treatment strategies have had limited 
or mixed success.9 To address these concerns, a web-based 
software for delivery of customized sound and music ther-
apy for tinnitus rehabilitation was previously developed by 
our group.11,12 The teleaudiological approach of the custom-
ized sound therapy enables delivery of sound therapy files 
via the Internet, which would provide ease of access for 
patients. The customized sound therapy protocol used here 
was previously shown to be effective in web-based tinnitus 
pitch matching and reducing the loudness and annoyance of 
Figure 2. Randomization process of the clinical trial.
Table 1. Demographics and Tinnitus Characteristics of Study 
Subjects (n = 18).
Demographics and Characteristics Frequency (%)
Gender
 Male 12 (67)
 Female 6 (33)
Tinnitus onset
 Sudden (<1 wk) 3 (17)
 Rapid (<1 mo) 3 (17)
 Gradual (>1 mo) 12 (66)
 Cannot recall 0 (0)
Onset-related factors
 Long-duration noise 5 (28)
 Brief nonexplosive noise 3 (17)
 Ear infection/inflammation 2 (11)
 Explosion (fireworks, gunfire, etc) 1 (6)
 Drugs, medication 0 (0)
 Stress 1 (6)
 Cannot recall 6 (33)
Tinnitus frequency in a week
 Everyday 17 (94)
 Most days (>3 d/wk) 1 (6)
Tinnitus frequency in a day
 Sometimes (<50% of the day) 1 (6)
 Most of time (>50% of the day) 2 (11)
 Whole day 15 (83)
Number of tinnitus sounds
 Ringing/tonal 8 (44)
 Buzzing/hissing 6 (33)
 Multiple sounds 4 (22)
Tinnitus noise-match
 Tonal 12 (66)
 Narrowband noise 3 (17)
 Broadband noise 3 (17)
Localization
 Both ears equal 5 (28)
 Both ears, left louder 5 (28)
 Both ears, right louder 2 (11)
 Left ear only 5 (28)
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tinnitus in a diverse group of subjects when used in short 
term (1 hour).12 In this study, we found that longer usage of 
the customized sound therapy is also effective and may be 
superior to simple broadband noise therapy in improving 
loudness and THI score.
The subjects had statistically significant reductions 
noted in loudness rating, THI, BAI, and MML after using 
the customized sound therapy for 3 months. Improvements 
were seen after broadband noise therapy, but these were 
relatively limited. Although the changes in the RI types 
were not statistically significant, there was a nearly 4-fold 
increase in the number of patients with complete RI. In a 
clinical setting, THI can be reliably used to quantify the 
impact of tinnitus on the daily living. The subjects in this 
trial had a pretrial THI of 42.8 ± 21.6, indicating “moder-
ate handicap.”14 After 3 months of customized sound ther-
apy, this decreased to 31.5 ± 20.3 (P < .001), representing 
a significant reduction to “mild handicap,” which would 
be considered barely noticeable and occasionally 
interfering with sleep. The anxiety levels as measured by 
the BAI had a statistically significant 25% reduction after 
broadband noise therapy and 22% reduction after the cus-
tomized sound therapy. Given that studies have indicated 
a high prevalence of anxiety, ranging from 29% to 49%,15,16 
a reduction in anxiety symptoms with both short-term and 
long-term use can be extremely beneficial to target some 
of the more debilitating psychosomatic sequelae of 
tinnitus.
Broadband noise therapy for 3 months yielded a 10% 
decrease in the MML and a 25% decrease on the BAI, with 
P = .03 and P = .004, respectively. There were no statisti-
cally significant changes in the loudness rating, THI, or 
BDI. Thus, it is notable that broadband noise therapy, 
although to some degree beneficial, may be less effective in 
reducing psychosomatic markers, which are significant 
indicators of the morbidity resulting from tinnitus. In addi-
tion, listening to a sound therapy mixed with music can be 
more pleasant and may perhaps be better tolerated by 
Table 2. Outcome Measurements at Baseline and at 3 Months After Customized Sound Therapy (n = 18).
Pretreatment
Mean ± SD (Median) or 
No. (%)
3 Months Posttreatment
Mean ± SD (Median) or 
No. (%)
Percentage of  
Change P-Value
Loudness rating 6.4 ± 2.0 (6.3) 4.9 ± 1.9 (5.0) −23 .001
THI 42.8 ± 21.6 (38.0) 31.5 ± 20.3 (25.0) −26 <.001
BAI 10.6 ± 10.9 (6.5) 8.3 ± 9.9 (4.5) −22 .01
BDI 6.7 ± 6.0 (5.0) 6.3 ± 8.6 (2.5) −6 .28
Minimum masking level (dB SL) 22.3 ± 11.6 (22.5) 17.2 ± 10.6 (15.0) −23 .005
Residual inhibition type .05
 Worse 1 (6) 0 (0) −100  
 No RI 10 (56) 8 (44) −20  
 Partial RI 6 (33) 6 (33) 0  
 Complete RI 1 (6) 4 (22) 300  
Residual inhibition duration (seconds) 35.0 ± 11.5 (30) 43.6 ± 25.8 (45) 24 .18
Abbreviations: BAI, Beck Anxiety Index; BDI, Beck Depression Index; RI, residual inhibition; THI, Tinnitus Handicap Inventory.
Table 3. Outcome Measurements at Baseline and at 3 Months After Broadband Noise Therapy (n = 18).
Pretreatment Mean ± SD 
(Median) or No. (%)
3 Months Posttreatment Mean 
± SD (Median) or No. (%)
Percentage of  
Change P-Value
Loudness rating 6.4 ± 2.0 (6.3) 6.1 ± 2.3 (5.5) −5 .22
THI 42.8 ± 21.6 (38.0) 41.0 ± 20.4 (33.0) −4 .25
BAI 10.6 ± 10.9 (6.5) 7.9 ± 9.8 (4.5) −25 .003
BDI 6.7 ± 6.0 (5.0) 6.9 ± 8.3 (5.5) −3 .69
Minimum masking level (dB SL) 22.3 ± 11.6 (22.5) 20.0 ± 9.9 (20.0) −10 .04
Residual inhibition type .9
 Worse 1 (6) 2 (11) 100  
 No RI 7 (39) 6 (33) −14  
 Partial RI 7 (39) 6 (33) −14  
 Complete RI 3 (17) 4 (22) 33  
Residual inhibition duration (seconds) 38.3 ± 14.7 (34.5) 42.3 ± 20.9 (42.0) 10 .38
Abbreviations: BAI, Beck Anxiety Index; BDI, Beck Depression Index; RI, residual inhibition; THI, Tinnitus Handicap Inventory.
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patients. Previous studies have introduced music therapy as 
an option in the treatment of both acute and chronic tinni-
tus.17,18 The customized nature of the sound therapy would 
allow for reduced overall acoustic energy delivery in com-
parison to broadband noise and leave a portion of the mid-
frequency sounds unmasked.
The crossover design in this study provided a powerful 
setting to compare the effects of the two arms of the study 
as each subject served as their own control. This design 
would minimize the variability between subjects with 
respect to potential confounding factors.19 Another advan-
tage of this design is the need for fewer subjects in compari-
son to parallel design trials to meet the same criteria in 
terms of type I and type II error risks.20 Depending on the 
degree of variability between subjects, a parallel design 
study might necessitate 4 to 6 times as many patients to 
achieve the same power. Most trials of therapies for tinnitus 
are not randomized, and many are poorly designed and 
without control groups.9 This study aimed to fill in this gap 
by studying sound therapy techniques in a randomized 
crossover fashion. This study is one of the first to directly 
compare a customized sound therapy to broadband noise 
therapy in a crossover setting.
There are a number of limitations associated with this 
approach to tinnitus management and this clinical trial, 
which need to be considered when interpreting its results. 
These include but are not limited to lack of improvement in 
the subjects’ tinnitus, worsening of the tinnitus, and the 
inability to maintain the benefit achieved in the sound ther-
apy. These  might have partially contributed to the follow-
up losses and dropouts. The stimulation may not reduce the 
tinnitus, which may lead to psychological distress such as 
anxiety or depression. Given significant reduction in the 
quality of life in tinnitus sufferers, administration of acous-
tic stimulus through headphones is a very small risk that is 
far outweighed by the possibility of suppressing the tinni-
tus. The 3-scale nature of the THI questionnaire may limit 
its sensitivity to perform a question by question analysis 
compared to 100-scale questionnaires.19,21 However, it is a 
validated questionnaire that has been used in various tinni-
tus studies.22,23 Another limitation of this study was the 
long-term nature of the study and the number of tests per-
formed on each subject, which required a significant amount 
of time dedicated by the subjects and made it difficult to 
achieve high numbers for enrollment. The time commit-
ment for the follow-up visits precluded 2 of the subjects to 
finish the study as their employment status changed during 
the study. Contralateral presentation of sound stimuli for 
audiometric pitch matching was used as a part of the psy-
choacoustic assessments of the subject. This technique may 
occasionally yield different pitch matches between the ear 
due to binaural diplacusis.24 However, the software used 
binaural presentation for pitch matching to create the sound 
files. The randomization of the starting arm and the washout 
period were considered to account for any possible carrying 
effect from one treatment to the other. Overall, the random-
ized and crossover design of this clinical trial provided a 
unique opportunity to evaluate the long-term outcomes of 
customized sound therapy and compare them to those of 
noncustomized therapy.
Conclusions
Customized sound therapy using the tested harmonic cus-
tomized sound therapy is an effective tool in the manage-
ment of tinnitus, and its effects may be superior to those of 
the broadband noise therapy. Customized sound therapy led 
to a decrease in mean loudness, THI, BAI, and MML. 
Broadband noise therapy only decreased the BAI and to a 
mild degree the MML.
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